Paul Dunkow Orthopaedics Limited 12468664 false 2022-03-01 2023-02-28 2023-02-28 The principal activity of the company is orthopaedics. Digita Accounts Production Advanced 6.30.9574.0 true true 12468664 2022-03-01 2023-02-28 12468664 2023-02-28 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2023-02-28 12468664 core:RetainedEarningsAccumulatedLosses 2023-02-28 12468664 core:ShareCapital 2023-02-28 12468664 core:CurrentFinancialInstruments 2023-02-28 12468664 core:CurrentFinancialInstruments core:WithinOneYear 2023-02-28 12468664 core:FurnitureFittingsToolsEquipment 2023-02-28 12468664 bus:SmallEntities 2022-03-01 2023-02-28 12468664 bus:AuditExemptWithAccountantsReport 2022-03-01 2023-02-28 12468664 bus:FullAccounts 2022-03-01 2023-02-28 12468664 bus:SmallCompaniesRegimeForAccounts 2022-03-01 2023-02-28 12468664 bus:RegisteredOffice 2022-03-01 2023-02-28 12468664 bus:Director1 2022-03-01 2023-02-28 12468664 bus:Director2 2022-03-01 2023-02-28 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-03-01 2023-02-28 12468664 bus:PrivateLimitedCompanyLtd 2022-03-01 2023-02-28 12468664 bus:Agent1 2022-03-01 2023-02-28 12468664 core:FurnitureFittings 2022-03-01 2023-02-28 12468664 core:FurnitureFittingsToolsEquipment 2022-03-01 2023-02-28 12468664 countries:EnglandWales 2022-03-01 2023-02-28 12468664 2022-02-28 12468664 core:FurnitureFittingsToolsEquipment 2022-02-28 12468664 2021-03-01 2022-02-28 12468664 2022-02-28 12468664 bus:OrdinaryShareClass1 bus:CumulativeShares 2022-02-28 12468664 core:RetainedEarningsAccumulatedLosses 2022-02-28 12468664 core:ShareCapital 2022-02-28 12468664 core:CurrentFinancialInstruments 2022-02-28 12468664 core:CurrentFinancialInstruments core:WithinOneYear 2022-02-28 12468664 core:FurnitureFittingsToolsEquipment 2022-02-28 iso4217:GBP xbrli:pure xbrli:shares

Registration number: 12468664

Paul Dunkow Orthopaedics Limited

Unaudited Filleted Financial Statements

for the Year Ended 28 February 2023

 

Paul Dunkow Orthopaedics Limited

Contents

Company Information

1

Accountants' Report

2

Balance Sheet

3 to 4

Notes to the Unaudited Financial Statements

5 to 9

 

Paul Dunkow Orthopaedics Limited

Company Information

Directors

Mr Paul David Dunkow

Dr Maria Anastasia Dunkow

Registered office

Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

Accountants

Crossley & Davis Chartered Accountants
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

 

Chartered Accountants' Report to the Board of Directors on the Preparation of the Unaudited Statutory Accounts of
Paul Dunkow Orthopaedics Limited
for the Year Ended 28 February 2023

In order to assist you to fulfil your duties under the Companies Act 2006, we have prepared for your approval the accounts of Paul Dunkow Orthopaedics Limited for the year ended 28 February 2023 as set out on pages 3 to 9 from the company's accounting records and from information and explanations you have given us.

As a practising member firm of the Institute of Chartered Accountants in England and Wales (ICAEW), we are subject to its ethical and other professional requirements which are detailed at
http://www.icaew.com/regulation.

This report is made solely to the Board of Directors of Paul Dunkow Orthopaedics Limited, as a body, in accordance with the terms of our engagement letter. Our work has been undertaken solely to prepare for your approval the accounts of Paul Dunkow Orthopaedics Limited and state those matters that we have agreed to state to the Board of Directors of Paul Dunkow Orthopaedics Limited, as a body, in this report in accordance with ICAEW Technical Release 07/16 AAF. To the fullest extent permitted by law, we do not accept or assume responsibility to anyone other than Paul Dunkow Orthopaedics Limited and its Board of Directors as a body for our work or for this report.

It is your duty to ensure that Paul Dunkow Orthopaedics Limited has kept adequate accounting records and to prepare statutory accounts that give a true and fair view of the assets, liabilities, financial position and profit of Paul Dunkow Orthopaedics Limited. You consider that Paul Dunkow Orthopaedics Limited is exempt from the statutory audit requirement for the year.

We have not been instructed to carry out an audit or a review of the accounts of Paul Dunkow Orthopaedics Limited. For this reason, we have not verified the accuracy or completeness of the accounting records or information and explanations you have given to us and we do not, therefore, express any opinion on the statutory accounts.

......................................

Crossley & Davis Chartered Accountants
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF

12 October 2023

 

Paul Dunkow Orthopaedics Limited

(Registration number: 12468664)
Balance Sheet as at 28 February 2023

Note

2023
£

2022
£

Fixed assets

 

Tangible assets

4

2,838

3,179

Current assets

 

Debtors

5

336,733

263,933

Cash at bank and in hand

 

801,881

424,373

 

1,138,614

688,306

Creditors: Amounts falling due within one year

6

(126,483)

(112,075)

Net current assets

 

1,012,131

576,231

Total assets less current liabilities

 

1,014,969

579,410

Provisions for liabilities

(568)

(604)

Net assets

 

1,014,401

578,806

Capital and reserves

 

Called up share capital

7

100

100

Retained earnings

1,014,301

578,706

Shareholders' funds

 

1,014,401

578,806

For the financial year ending 28 February 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and

The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the directors have not delivered to the registrar a copy of the Profit and Loss Account.

Approved and authorised by the Board on 12 October 2023 and signed on its behalf by:
 

 

Paul Dunkow Orthopaedics Limited

(Registration number: 12468664)
Balance Sheet as at 28 February 2023

.........................................
Mr Paul David Dunkow
Director

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

1

General information

The company is a private company limited by share capital, incorporated in England and Wales.

The address of its registered office is:
Ground Floor, Seneca House
Links Point, Amy Johnson Way
Blackpool
Lancashire
FY4 2FF
England

These financial statements were authorised for issue by the Board on 12 October 2023.

2

Accounting policies

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A smaller entities - 'The Financial Reporting Standard applicable in the United Kingdom and Republic of Ireland' and the Companies Act 2006 (as applicable to companies subject to the small companies' regime).

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value.

Going concern

The financial statements have been prepared on a going concern basis.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts.

The company recognises revenue when:
The amount of revenue can be reliably measured;
it is probable that future economic benefits will flow to the entity;
and specific criteria have been met for each of the company's activities.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.

Unrelieved tax losses and other deferred tax assets are recognised when it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.

The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Depreciation

Depreciation is charged so as to write off the cost of assets, other than land and properties under construction over their estimated useful lives, as follows:

Asset class

Depreciation method and rate

Fixtures and fittings

25% straight line basis

Cash and cash equivalents

Cash and cash equivalents comprise cash on hand and call deposits, and other short-term highly liquid investments that are readily convertible to a known amount of cash and are subject to an insignificant risk of change in value.

Trade debtors

Trade debtors are amounts due from customers for merchandise sold or services performed in the ordinary course of business.

Trade debtors are recognised initially at the transaction price. They are subsequently measured at amortised cost using the effective interest method, less provision for impairment. A provision for the impairment of trade debtors is established when there is objective evidence that the company will not be able to collect all amounts due according to the original terms of the receivables.

Trade creditors

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Accounts payable are classified as current liabilities if the company does not have an unconditional right, at the end of the reporting period, to defer settlement of the creditor for at least twelve months after the reporting date. If there is an unconditional right to defer settlement for at least twelve months after the reporting date, they are presented as non-current liabilities.

Trade creditors are recognised initially at the transaction price and subsequently measured at amortised cost using the effective interest method.

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

Share capital

Ordinary shares are classified as equity. Equity instruments are measured at the fair value of the cash or other resources received or receivable, net of the direct costs of issuing the equity instruments. If payment is deferred and the time value of money is material, the initial measurement is on a present value basis.

Dividends

Dividend distribution to the company’s shareholders is recognised as a liability in the financial statements in the reporting period in which the dividends are declared.

Defined contribution pension obligation

A defined contribution plan is a pension plan under which fixed contributions are paid into a pension fund and the company has no legal or constructive obligation to pay further contributions even if the fund does not hold sufficient assets to pay all employees the benefits relating to employee service in the current and prior periods.

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

3

Staff numbers

The average number of persons employed by the company (including directors) during the year, was 3 (2022 - 4).

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

4

Tangible assets

Furniture, fittings and equipment
 £

Total
£

Cost or valuation

At 1 March 2022

4,667

4,667

Additions

1,080

1,080

At 28 February 2023

5,747

5,747

Depreciation

At 1 March 2022

1,488

1,488

Charge for the year

1,421

1,421

At 28 February 2023

2,909

2,909

Carrying amount

At 28 February 2023

2,838

2,838

At 28 February 2022

3,179

3,179

5

Debtors

Current

2023
£

2022
£

Trade debtors

319,653

248,391

Prepayments

17,080

15,085

Other debtors

-

457

 

336,733

263,933

6

Creditors

Creditors: amounts falling due within one year

2023
£

2022
£

Due within one year

Taxation and social security

111,790

100,336

Accruals and deferred income

8,460

4,610

Other creditors

6,233

7,129

126,483

112,075

 

Paul Dunkow Orthopaedics Limited

Notes to the Unaudited Financial Statements for the Year Ended 28 February 2023

7

Share capital

Allotted, called up and fully paid shares

 

2023

2022

 

No.

£

No.

£

Ordinary share capital of £1 each

100

100

100

100